2019
DOI: 10.25156/ptj.v9n2y2019.pp25-29
|View full text |Cite
|
Sign up to set email alerts
|

Simultaneous Determination of Atenolol and Amlodipine Using Second Derivative Spectroscopy

Abstract: The present study describes employing second derivative spectrophotometry for simultaneous determination of atenolol and amlodipine in pure form and in commercial formulations. The method is simple, accurate, precise and economic. Zero crossing point technique was used for analysis of the drugs in the combined formulation. The method was found to be linear in the concentration range 5.0-50.0µg/ml of atenolol at 251nm and 5.0-45.0µg/ml of amlodipine at 264nm. The proposed method was successfully applied to dete… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 7 publications
0
3
0
Order By: Relevance
“…Also, under the same condition, when the simultaneous determination of the different concentrations of ALP in the presence of 5-45 μg/mL LSD, we selected 215, 254, and 277 nm where LSD has a zero-crossing point at these wavelengths, as shown in Figure 5. The LSD and ALP concentration range was selected according to the zero-crossing point [16]. Based on this, the peak to baseline [17] can be used to measure LSD concentrations separately or simultaneously at 203, 207, and 231 nm and ALP at 215, 254, and 277 nm.…”
Section: Simultaneous Determination Of Lsd and Alpmentioning
confidence: 99%
“…Also, under the same condition, when the simultaneous determination of the different concentrations of ALP in the presence of 5-45 μg/mL LSD, we selected 215, 254, and 277 nm where LSD has a zero-crossing point at these wavelengths, as shown in Figure 5. The LSD and ALP concentration range was selected according to the zero-crossing point [16]. Based on this, the peak to baseline [17] can be used to measure LSD concentrations separately or simultaneously at 203, 207, and 231 nm and ALP at 215, 254, and 277 nm.…”
Section: Simultaneous Determination Of Lsd and Alpmentioning
confidence: 99%
“…These include voltammetry methods for ATE analysis in pharmaceutical products (Moraes et al, 2016) and urine (Afonso et al, 2016), GC-MS method for the analysis of ATE and bisoprolol in human bone (Fernandez-Lopez et al, 2019), and UPLC-MS for the analysis of ATE and chlorthalidone in human plasma (Shah et al, 2016). Also, different mixtures containing ATE were analyzed using HPLC methods (Anderson et al, 2017;El-Alfy et al, 2019;Elkady et al, 2020;Kannappan & Mannemala, 2016) in addition to spectrophotometry (Antakli et al, 2020;Mohammad et al, 2019;Saleem, 2019;Vaikosen et al, 2020) and capillary electrophoresis (Kuraeva et al, 2016). Tabrizi et al (Tabrizi & Yousefzadeh, 2019) developed a spectrofluorimetric method for the determination of ATE and carvedilol in pharmaceutical preparations, while Damiani et al developed a spectrofluorimetric method for the determination of ATE in human urine by emissionexcitation fluorescence matrices (Damiani, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…In literature research, UV-Visible spectrophotometry (Saleem, 2019;Antakli et al, 2020;Mohammad et al, 2019;Vaikosen et al, 2020), spectrofluorometry (Tabrizi and Yousefzadeh, 2019), high-performance liquid chromatography (HPLC) (Pires de Abreu et al, 2003;Iha et al,. 2002;Chiu et al, 1997;Madhusudhan et al, 2018;El-Alfy et al, 2019;Elkady et al, 2020), gas chromatography-mass spectrometry (GC-MS) (Yilmaz et al, 2009) and capillary electrophoresis (Arias et al, 2001) methods for determining atenolol in invitro conditions and biological materials have been reached.…”
Section: Introductionmentioning
confidence: 99%